Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Industry News

Luminex Enters Agreement to Acquire Nanosphere

Luminex Corporation (Austin, TX, USA) and Nanosphere, Inc. (Northbrook, IL, USA) have entered into a definitive agreement under which Luminex will acquire Nanosphere, a leader in molecular microbiology and diagnostics, in an all-cash transaction valued at approximately USD 77 million (USD 1.70 per share). More...
26 May 2016

Sysmex and Siemens Extend Partnership in Hemostasis Testing

Sysmex Corporation (Kobe, Japan) and Siemens Healthcare Laboratory Diagnostics (NY, USA) have announced an extension to their long-standing partnership through at least 2020. The contract extension adds a minimum of two additional years to the global supply, distributorship, and sales and service agreement for hemostasis clinical testing products. More...
26 May 2016

In Vitro Diagnostics Market to Witness Swift Growth

The global in vitro diagnostics (IVD) market is expected to expand rapidly owing to an aging population, chronic lifestyle related diseases, and increased usage of personalized medicine and point-of-care (POC) testing. These are the latest findings of Grand View Research (San Francisco, CA, USA), a market research and consulting company. More...
26 May 2016

DiaSorin Enters U.S. Molecular and Immunoassay Market

DiaSorin (Saluggia, Italy) and Quest Diagnostics (Madison, NJ, USA) have announced an agreement under which DiaSorin will buy the Focus Diagnostics (Cypress, CA, UYA) immunodiagnostic and molecular diagnostic products business. More...
26 May 2016

R-Biopharm and Merck Partner on Companion Diagnostics

R-Biopharm AG and Merck KGaA have entered into an agreement that constitutes their first collaboration, which will initially focus on developing and launching companion diagnostics.  More...
10 Apr 2016

Near-Patient Molecular Diagnostics Forecasted to USD 1 Billion

Although currently the sector of point-of-care and near-patient molecular diagnostic solutions is less than USD 100 million, it is likely to grow to over USD 1 billion by 2020, according to a new healthcare market analysis.  More...
28 Mar 2016
Image: The HTG Edge system which provides easy to use, walkaway automation for multiplexed profiling panels (HTG Molecular Diagnostics).

HTG Molecular Diagnostics Announces IVD Development Agreement with Thermo Fisher Scientific

HTG Molecular Diagnostics, a provider of instruments and reagents for molecular profiling applications, have announced that it has entered into a long-term agreement with Thermo Fisher Scientific under which HTG will have the right to develop a number of in vitro diagnostic tests for use with Thermo Fisher’s next-generation sequencing Ion PGM Dx System.  More...
27 Mar 2016


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2016 Globetech Media. All rights reserved.